
Sartorius Stedim Biotech Investor Relations Material
Latest events

Q2 2025
Sartorius Stedim Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sartorius Stedim Biotech S.A.
Access all reports
Sartorius Stedim Biotech S.A. is a global supplier of biopharmaceutical equipment and services, specializing in the development of products used in the manufacture of vaccines, biologics, and cell-based therapies. The company offers a wide range of solutions, including bioreactors, filtration systems, and single-use technologies, aimed at optimizing and accelerating biopharmaceutical production processes. The company is headquartered in Aubagne, France, and its shares are listed on Euronext Paris.
Key slides for Sartorius Stedim Biotech S.A.


Q2 2025
Sartorius Stedim Biotech S.A.


Q2 2025
Sartorius Stedim Biotech S.A.
Latest articles
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
Ticker symbol
DIM
Country
🇫🇷 France